Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 29, Issue 10, Pages 1382-1391Publisher
AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2010.28.2319
Keywords
-
Categories
Funding
- The European Fine Art Foundation
- Center for Translational Molecular Medicine [03O-101]
- Zorg Onderzoek Nederland Medische Wetenschappen [6120.0022]
Ask authors/readers for more resources
Colorectal cancer (CRC) has predominantly been considered a genetic disease, characterized by sequential accumulation of genetic alterations. Growing evidence indicates that epigenetic alterations add an additional layer of complexity to the pathogenesis of CRC, and characterize a subgroup of colorectal cancers with a distinct etiology and prognosis. Epigenetic dysregulation in colorectal cancer is organized at multiple levels, involving DNA methylation, histone modifications, nucleosomal occupancy and remodeling, chromatin looping, and noncoding RNAs. Interactions between these processes and complex associations with genetic alterations have recently been unraveled. It appears that CRC epigenetics will be the paradigm for multistep carcinogenesis, as CRC genetics has been for the past three decades. This review integrates recent data on epigenetic regulation of gene expression in CRC and describes how the understanding of these processes will alter the management of CRC. J Clin Oncol 29: 1382-1391. (C) 2011 by American Society of Clinical Oncology
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available